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Iron-sulfur proteins are among the primary targets of nitric
oxide in cells. Previous studies have shown that iron-sulfur clus-
ters hosted by cysteine residues in proteins are readily disrupted
by nitric oxide forming a protein-bound dinitrosyl iron com-
plex, thiolate-bridged di-iron tetranitrosyl complex, or octani-
trosyl cluster.Herewe report that humanmitochondrial protein
Miner2 [2Fe-2S] clusters can bind nitric oxide without disrup-
tion of the clusters. Miner2 is a member of a new CDGSH iron-
sulfur protein family that also includes two mitochondrial pro-
teins: the type II diabetes-related mitoNEET and the Wolfram
syndrome 2-linked Miner1. Miner2 contains two CDGSH
motifs, and eachCDGSHmotif hosts a [2Fe-2S] cluster via three
cysteine and one histidine residues. Binding of nitric oxide in
the reducedMiner2 [2Fe-2S] clusters produces a major absorp-
tion peak at 422 nm without releasing iron or sulfide from the
clusters. The EPRmeasurements and mass spectrometry analy-
ses further reveal that nitric oxide binds to the reduced [2Fe-2S]
clusters in Miner2, with each cluster binding one nitric oxide.
Although the [2Fe-2S] cluster in purified humanmitoNEET and
Miner1 fails to bind nitric oxide, a single mutation of Asp-96 to
Val in mitoNEET or Asp-123 to Val in Miner1 facilitates nitric
oxide binding in the [2Fe-2S] cluster, indicating that a subtle
change of protein structure may switch mitoNEET and Miner1
to bind nitric oxide. The results suggest that binding of nitric
oxide in the CDGSH-type [2Fe-2S] clusters in mitochondrial
proteinMiner2may represent a newnitric oxide signalingmode
in cells.
Iron-sulfur clusters in proteins are often hosted by cysteine
residues, although histidine, glutamine, serine, or arginine can
also be the ligands (1, 2). Recently, a new group of iron-sulfur
proteins that contain one or two CDGSH motifs have been
identified in eukaryotes, archaea, and several bacteria (3). A
common feature of theCDGSHproteins is that they host one or
two [2Fe-2S] clusters via an unusual ligand arrangement of
three cysteine and one histidine residues (3). In human mito-
chondria, there are three CDGSH iron-sulfur domain (CISD)2
proteins: mitoNEET (CISD1) (4), Miner1 (mitoNEET-related
protein 1, CISD2, or NAF-1) (5, 6), and Miner2 (mitoNEET-
related protein 2, CISD3) (7). MitoNEET, a target of the type II
diabetes drug pioglitazone (4), localizes on the mitochondrial
outermembrane and exists as a homodimer (7). Eachmonomer
of mitoNEET contains a CDGSHmotif that hosts one [2Fe-2S]
cluster (8–10).Miner1 has 54% identity and 76% similarity with
mitoNEET (5) and also localizes on the mitochondrial outer
membrane (11). Like mitoNEET, each monomer of theMiner1
homodimer contains a CDGSH motif that hosts one [2Fe-2S]
cluster (5). Mutation of Miner1 has been attributed to causing
Wolfram syndrome 2, a disease characterized by juvenile-onset
diabetes mellitus and optic atrophy (12). Both mitoNEET and
Miner1 have central roles in regulating iron homeostasis,
energy metabolism, and production of free radicals in mito-
chondria (11, 13). Recent studies further suggested that
mitoNEET may transfer its [2Fe-2S] clusters to target proteins
in the cytoplasm (14, 15) or directly regulate mitochondrial
functions via the redox transition of the [2Fe-2S] clusters (16–
18). Miner2 contains an N-terminal mitochondrial signal pep-
tide and two CDGSH motifs. Although mitochondrial Miner2
is found to be highly expressed in lung cancer, breast cancer,
and other types of cancer (Cancer Browser), it has not been
purified or characterized previously, and very little is known
about the function of Miner2 in mitochondria. Nevertheless,
the crystal structure of the Miner2 homolog from Magnetospi-
rillum magneticum shows thatMiner2 is amonomer that hosts
two [2Fe-2S] clusters via two CDGSH motifs in an internal
pseudodyad symmetry (3).
Ironically, iron-sulfur clusters are among the primary targets
of the physiological free radical nitric oxide, as nitric oxide has
a strong reactivity with ferrous iron in proteins (19). In bacteria,
nitric oxide regulates global gene expression via direct modifi-
cation of iron-sulfur clusters in several transcription factors
(20–24). At high concentrations, nitric oxide inhibits bacterial
cell growth by disrupting iron-sulfur clusters in multiple
enzymes (21, 25, 26). In mitochondria, nitric oxide has been
shown to modulate energy metabolism by interacting with
iron-sulfur clusters and hemes in proteins (27). For example,
nitric oxide directly modifies the [4Fe-4S] cluster in mitochon-
drial aconitase and blocks the citric acid cycle (28). Among the
reported examples so far, iron-sulfur clusters in proteins are all
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disrupted by nitric oxide forming a protein-bound dinitrosyl
iron complex (25–29), thiolate-bridged di-iron tetranitrosyl
complex (30, 31), or octanitrosyl cluster (32), depending on
specific proteins and experimental conditions. In all of these
examples, iron-sulfur clusters in proteins are hosted by either
cysteine residues (33) or Rieske-type two histidine and two cys-
teine residues (34). Here, we report that the CDGSH-type [2Fe-
2S] clusters in the human mitochondrial protein Miner2 can
bind nitric oxide without disruption of the clusters. Although
the [2Fe-2S] cluster in purified human mitoNEET and Miner1
fails to bind nitric oxide, a single mutation of Asp-96 to Val in
mitoNEET or Asp-123 to Val in Miner1 facilitates nitric oxide
binding in the [2Fe-2S] clusters, indicating that a subtle change
of protein structure may switchmitoNEET andMiner1 to bind
nitric oxide at the [2Fe-2S] cluster. The results suggest that
binding of nitric oxide in the CDGSH-type [2Fe-2S] clusters in
mitochondrial protein Miner2 may represent a novel nitric
oxide signaling mode in cells.
Results
Human Miner2 [2Fe-2S] Clusters Have a Unique Interaction
with Nitric Oxide—The recombinant human mitochondrial
CDGSH proteins mitoNEET, Miner1, and Miner2 were pre-
pared from Escherichia coli cells as described under “Experi-
mental Procedures.” Fig. 1A shows that purified human
mitoNEET, Miner1, and Miner2 had a similar UV-visible
absorption spectrum, with two major absorption peaks at 458
and 550 nm, indicative of the oxidized [2Fe-2S] clusters in each
protein (35). When purified proteins were reduced with dithi-
othreitol under anaerobic conditions (17), mitoNEET and
Miner1 had an identical EPR spectrum with g  1.94 of the
reduced [2Fe-2S] clusters (Fig. 1B), as reported previously (35,
36). This is likely because mitoNEET and Miner1 have 54%
identity and 76% similarity (5). In contrast, the reducedMiner2
appeared to have twooverlapping EPR spectra (Fig. 1B). Decon-
volution of the EPR spectrum of the reducedMiner2 produced
two distinct EPR spectra with g  1.92 and g  1.94, respec-
tively (Fig. 1C), suggesting that humanMiner2, like theMiner2
homolog from M. magneticum (3), hosts two [2Fe-2S] clusters
via two CDGSH motifs.
As the redoxmidpoint potential (Em7) of the [2Fe-2S] cluster
in mitoNEET is about 0 mV (37), the CDGSH-type [2Fe-2S]
clusters in proteins are most likely in a reduced state in cells
under normal physiological conditions (17). To explore the
interaction between the mitochondrial CDGSH proteins and
nitric oxide, purifiedmitoNEET,Miner1, andMiner2were pre-
reducedwith dithiothreitol before being exposed to nitric oxide
under anaerobic conditions. When reduced mitoNEET or
Miner1 was treated with a 2-fold excess of nitric oxide (from a
nitric oxide gas-saturated solution), the UV-visible absorption
spectrum of the [2Fe-2S] cluster in mitoNEET (Fig. 2A) or
Miner1 (Fig. 2B) was not significantly changed, indicating that
the [2Fe-2S] cluster in mitoNEET or Miner1 did not interact
with nitric oxide under the experimental conditions. In con-
trast, when reduced Miner2 was treated with a 2-fold excess of
nitric oxide, a new absorption peak at 422 nm appeared (Fig.
2C). No detectable amount of iron or sulfide was released from
the Miner2 [2Fe-2S] clusters after nitric oxide treatment (data
not shown), indicating that nitric oxidemay bind to theMiner2
[2Fe-2S] clusters without disrupting them. In a control experi-
ment, when reduced apo-Miner2 (Miner2 without the [2Fe-2S]
clusters) was treated with a 2-fold excess of nitric oxide under
anaerobic conditions, no absorption peak at 422 nm was
observed (data not shown), further suggesting that the absorp-
tion peak at 422 nm is likely due to the interaction between the
Miner2 [2Fe-2S] clusters and nitric oxide.
Under the same experimental conditions, E. coli SoxR, which
hosts a [2Fe-2S] cluster via four cysteine residues (38), was
treated with a 2-fold excess of nitric oxide under anaerobic
conditions. Fig. 2D shows that the absorption peaks at 414 and
462 nm of the SoxR [2Fe-2S] clusters were largely eliminated,
with no appearance of the absorption peak at 422 nm after
nitric oxide treatment, confirming that the SoxR [2Fe-2S] clus-
ters were disrupted by nitric oxide forming a protein-bound dini-
trosyl iron complex, as reported previously (20). Thus, theMiner2
[2Fe-2S] clusters have a unique interaction with nitric oxide.
The Miner2 [2Fe-2S] Clusters Have a Strong Binding Affinity
for Nitric Oxide—To further explore the interaction between
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FIGURE 1. UV-visible and EPR spectra of human mitoNEET, Miner1, and
Miner2. A, UV-visible absorption spectra of purified mitoNEET, Miner1, and
Miner2. MitoNEET, Miner1, and Miner2 were purified as described under
“Experimental Procedures.” Each protein (containing 20 M [2Fe-2S] cluster)
was dissolved in buffer containing NaCl (500 mM) and Tris (20 mM (pH 8.0)).
O.D., optical density. B, EPR spectra of purified humanmitoNEET, Miner1, and
Miner2. Each protein (containing 20 M [2Fe-2S] cluster) was dissolved in
buffer containing NaCl (500 mM) and Tris (20 mM (pH 8.0)) and reduced with
dithiothreitol (4mM)under anaerobic conditions.mT,millitesla.C, EPR spectra
ofMiner2.Top spectrum, dithiothreitol-reducedMiner2 [2Fe-2S]clusters.Spectra
1 and 2were the results of the deconvolution of the top spectrum using simula-
tion software. The g values of the deconvoluted spectra are shown.
NO Binding in Miner2 [2Fe-2S] Clusters
FEBRUARY 24, 2017•VOLUME 292•NUMBER 8 JOURNAL OF BIOLOGICAL CHEMISTRY 3147
reduced with dithiothreitol, followed by stepwise addition of
nitric oxide under anaerobic conditions. UV-visible absorption
spectra were taken after each addition of nitric oxide. Fig. 3A
shows that, as the nitric oxide concentration increased in the
incubation solution, the absorption peak at 422 nm gradually
increased. The amplitude of the absorption peak at 422 nmwas
almost linearly proportional to the nitric oxide concentration in
the incubation solution. An about 2-fold excess of nitric oxide
over Miner2 was sufficient to saturate the nitric oxide binding
in the Miner2 [2Fe-2S] clusters (Fig. 3B), indicating that the
Miner2 [2Fe-2S] clusters have a strong binding affinity for
nitric oxide.
In parallel experiments, after reduced Miner2 was treated
with stepwise addition of nitric oxide under anaerobic condi-
tions, samples were immediately frozen in liquid nitrogen and
subjected to EPR measurements. Fig. 3C shows that, as nitric
oxide concentration increased in the incubation solution, the
EPR signal at g 1.92 of the reduced Miner2 [2Fe-2S] clusters
gradually decreased. At 2-fold excess of nitric oxide over
Miner2, the EPR signal at g  1.92 was largely eliminated. A
small EPR signal at g  2.03, indicative of a protein-bound
dinitrosyl iron complex (26, 28), appeared after theMiner2 was
treatedwith nitric oxide (Fig. 3C). However, spin quantification
of the EPR signal at g  2.04 showed that less than 5% of the
reduced Miner2 [2Fe-2S] clusters might be converted to
the dinitrosyl iron complex, suggesting that the majority of the
reduced Miner2 [2Fe-2S] clusters became EPR-silent after
being treated with a 2-fold excess of nitric oxide.
To further test the idea that nitric oxide binds to the Miner2
[2Fe-2S] clusters, the nitric oxide-treated Miner2 was repuri-
fied from the incubation solution by passing the protein sample
through a High-Trap desalting column. RepurifiedMiner2 was
then treated with 0.2 M HCl to release the acid-labile iron and
sulfide from iron-sulfur clusters in the protein. Fig. 3D shows
that more than 80% of the acid-labile iron and sulfide content
remained with Miner2 after being treated with a 2-fold excess
of nitric oxide. Thus, nitric oxide may eliminate the EPR signal
at g 1.92 of the reduced Miner2 [2Fe-2S] clusters by directly
binding to the clusters.
Mass Spectrometry Analyses of the Nitric Oxide-bound
Miner2—L-cysteine has been used to release nitric oxide (in the
formof nitrite) from the protein-bounddinitrosyl iron complex
under aerobic conditions (26). To probe the nitric oxide bind-
ing in the Miner2 [2Fe-2S] clusters, the nitric oxide-treated
Miner2 was repurified and incubated with L-cysteine at 37 °C
under aerobic conditions for 30 min. Nitrite released from
Miner2 wasmeasured usingGriess reagents (26). Fig. 3D shows
that nitrite was indeed released when the nitric oxide-treated
Miner2 was incubated with 10 mM L-cysteine under aerobic
conditions. The ratio of nitrite to total iron in the nitric oxide-
treated Miner2 was about 0.41  0.12, indicating that each
[2Fe-2S] cluster in Miner2 binds about one nitric oxide. For
Miner2 without nitric oxide treatment, no detectable amount
of nitrite was observed after incubation with 10 mM L-cysteine.
Mass spectrometry was further used to analyze the nitric
oxide binding in the Miner2 [2Fe-2S] clusters. Fig. 4A shows
that purified Miner2 had a major peak at a molecular weight of
10,878, which is the sum of the expected molecular weight of
apo-Miner2 (10,526) plus 2  [2Fe-2S] clusters (352). When
Miner2 was exposed to a 2-fold excess of nitric oxide, the peak
at 10,878 was largely eliminated and replaced with two new
peaks at molecular weights of 10,878  30 and 10,878  60,
respectively (Fig. 4A). As themolecular weight of nitric oxide is
30, two new peaks were assigned to the Miner2 with only one
[2Fe-2S] cluster bound with nitric oxide and the one with both
[2Fe-2S] clusters bound with nitric oxide, respectively. Missing
a nitric oxide in theMiner2 [2Fe-2S] clusters could be because,
during ionization in the mass spectrometry analysis, some
nitric oxide was released from the clusters.
A minor peak at a molecular weight of 10,526 representing
apo-Miner2 was also observed in the samemass spectrum (Fig.
4B). Unlike themajor peak at 10,878 (theMiner2 [2Fe-2S] clus-
ters), the minor peak at 10,536 (apo-Miner2) was not changed
after nitric oxide treatment (Fig. 4B), suggesting that apo-
Miner2 did not bind or react with nitric oxide under the exper-
imental conditions.
A Single Amino Acid Mutation in mitoNEET and Miner1
Facilitates Nitric Oxide Binding in the [2Fe-2S] Cluster—Like
Miner2, mitoNEET and Miner1 contain a CDGSH motif that
hosts a [2Fe-2S] cluster via three cysteine and one histidine
residues (5, 8–10). However, unlike the reduced Miner2 [2Fe-
2S] clusters, the reducedmitoNEET [2Fe-2S] cluster orMiner1
[2Fe-2S] cluster fails to bind nitric oxide (Fig. 2, A and B). One
possible explanation is that, in purifiedmitoNEET andMiner1,
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FIGURE2.Nitric oxide binding in human mitoNEET, Miner1 and Miner2.A,
purified mitoNEET (containing 20 M [2Fe-2S] cluster) in buffer containing
NaCl (500mM)andTris (20mM (pH8.0))was reducedwithdithiothreitol (4mM)
under anaerobic conditions before (spectrum 1) and after (spectrum 2) addi-
tion of 40M nitric oxide anaerobically.O.D., optical density. B, the same as in
A, except purifiedMiner1wasused.C, the sameas inA, except purifiedMiner2
was used. D, the same as in A, except purified E. coli SoxR was used.
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the protein conformation does not favor nitric oxide binding
to the [2Fe-2S] clusters in the protein. Based on the crystal
structure of mitoNEET (8–10), the [2Fe-2S] cluster is buried
inside the protein structure, and Asp-96 is in the vicinity of the
[2Fe-2S] cluster and potentially blocks the access of nitric oxide to
the [2Fe-2S] cluster inmitoNEET (supplemental Figs. 2A and 2B).
To test this idea, a mitoNEET mutant in which Asp-96 was
replaced with Val (D96V) was constructed using site-directed
mutagenesis. Fig. 5B shows that the reduced [2Fe-2S] cluster in
the mitoNEET mutant (D96V) could indeed bind nitric oxide
under anaerobic conditions. The mass spectrometry analysis
further revealed that the mitoNEET mutant binds one nitric
oxide per [2Fe-2S] cluster (supplemental Fig. 2C). Similar
results were also observed in theMiner1 mutant in which Asp-
123 (corresponding to Asp-96 of mitoNEET) was mutated to
Val (data not shown). Thus, with a subtle structural change, the
[2Fe-2S] cluster in mitoNEET and Miner1 has a similar nitric
oxide binding activity as the Miner2 [2Fe-2S] clusters.
Discussion
Hemes and iron-sulfur clusters are the major iron-contain-
ing co-factors in proteins and are also the primary targets of
nitric oxide (19). Although nitric oxide binding in ferrous heme
iron in proteins has been extensively investigated and well
understood (19, 27), much less has been known about the inter-
actions between nitric oxide and iron-sulfur clusters in pro-
teins. In previous studies, iron-sulfur clusters in proteins were
found to be completely disrupted by nitric oxide forming a pro-
tein-bound dinitrosyl iron complex (25–29), thiolate-bridged
di-iron tetranitrosyl complex (30, 31), or octanitrosyl cluster
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FIGURE 3. The nitric oxide binding activity of Miner2. A, UV-visible absorption spectra of Miner2. Purified Miner2 (containing 20 M [2Fe-2S] cluster) was
prereduced with dithiothreitol (4 mM) under anaerobic conditions, followed by stepwise addition of nitric oxide (from a nitric oxide-saturated solution)
anaerobically. Spectra were taken after each addition of nitric oxide. B, the amplitudes of the absorption peak at 422 nm of the Miner2 [2Fe-2S] clusters were
plotted as a function of the nitric oxide concentrations in incubation solutions. The results are representative of three independent experiments.C, EPR spectra
of Miner2. Purified Miner2 (containing 20 M [2Fe-2S] cluster) was prereduced with dithiothreitol (4 mM) under anaerobic conditions, followed by stepwise
addition of nitric oxide anaerobically. Samples were immediately frozen in liquid nitrogen and subjected to the EPR measurements. mT, millitesla. D, iron,
sulfide, andnitrite content analyses ofMiner2.Miner2was repurified after treatment of a 2-fold excess of nitric oxide under anaerobic conditions. The amounts
of iron, sulfide, andnitriteweremeasuredasdescribedunder “Experimental Procedures.” In threedifferentpreparations, the iron content inMiner2 varied from
3.5 to 2.0 iron atoms perMiner2. For each preparation ofMiner2, the ratio of iron toMiner2 was set to 1.0, and other content was calculated based on the ratio
of iron toMiner2. The amount of nitrite in theMiner2 samplewithout nitric oxide treatmentwas not detectable. Data aremean S.D. from three experiments.
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(32), depending on specific proteins and experimental condi-
tions. Such modifications of iron-sulfur clusters by nitric oxide
have also been demonstrated in iron-sulfur cluster model com-
pounds (39, 40). However, in all of these reported examples,
iron-sulfur clusters in proteins are hosted by either all cysteine
residues (33) or Rieske-type two histidine and two cysteine res-
idues (34). Our finding that the reduced CDGSH-type [2Fe-2S]
clusters of human mitochondrial protein Miner2 are able to
bind nitric oxide without disruption of the clusters represents a
new interaction between nitric oxide and iron-sulfur clusters in
proteins. In the CDGSH-type [2Fe-2S] cluster, which is hosted
by three cysteine and one histidine residues, two iron atoms are
asymmetric as one iron is bound by two cysteine residues and
the other by one cysteine and one histidine residues (Fig. 6).
When the [2Fe-2S] cluster is oxidized, both iron atoms in the
cluster are in a ferric state. When the [2Fe-2S] cluster is
reduced, the histidine-bound iron atomwill be in a ferrous state
(41). Because nitric oxide prefers to bind ferrous iron (19), we
propose that the ferrous iron in the reduced Miner2 [2Fe-2S]
clusters is likely the nitric oxide binding site (Fig. 6). The
observed absorption peak at 422 nm of the reduced Miner2
[2Fe-2S] clusters after nitric oxide treatment (Fig. 2C) may rep-
resent the Soret absorption for the interaction between nitric
oxide and the ferrous iron of the [2Fe-2S] clusters inMiner2. A
similar Soret absorption around 420 nm has been attributed to
nitric oxide binding to the ferrous heme iron in the heme nitric
oxide/oxygen binding protein isolated from Clostridium botu-
linum (42) and in the thiolate-ligated ferrous cytochrome P450
of the neuronal nitric oxide synthase (43). Binding of nitric
oxide in the Miner2 [2Fe-2S] clusters apparently changes the
redox state of the ferrous iron of the clusters, as binding of nitric
oxide eliminates the EPR signal at g  1.92 of the reduced
Miner2 [2Fe-2S] clusters (Fig. 3C). We also noticed that the
interaction between nitric oxide and the Miner2 [2Fe-2S] clus-
ters is stable, as the nitric oxide-boundMiner2 [2Fe-2S] clusters
can be purified and directly observed from the mass spectrom-
etry analysis (Fig. 4A). Although additional spectroscopic stud-
ies are needed to further illustrate the nitric oxide binding in the
Miner2 [2Fe-2S] clusters, we postulate that binding of nitric
oxide in theMiner2 [2Fe-2S] clustersmay regulate the function
of the protein in mitochondria.
Unlike the reduced [2Fe-2S] clusters in Miner2, the reduced
[2Fe-2S] cluster in mitoNEET or Miner1 fails to bind nitric
oxide (Fig. 2). Nevertheless, a single mutation of Asp-96 to Val
in mitoNEET facilitates nitric oxide binding in the [2Fe-2S]
cluster (Fig. 5). Similarly, the [2Fe-2S] cluster in the Miner1
mutant with Asp-123mutated to Val (corresponding to Asp-96
of mitoNEET) can also bind nitric oxide. These results suggest
that a subtle change in protein structuremay switchmitoNEET
and Miner1 to facilitate nitric oxide binding in the [2Fe-2S]
clusters. As mitoNEET and Miner1 have specific interactions
with multiple mitochondrial proteins, including the Parkin-
son’s disease-associated protein Parkin (44, 45), such protein-
protein interactions may well change the conformation of
mitoNEET and Miner1 and facilitate the [2Fe-2S] cluster to
bind nitric oxide. It is also possible that posttranslational
modifications such as phosphorylation and acetylation of
mitoNEETandMiner1may promote nitric oxide binding in the
[2Fe-2S] cluster. Although both mitoNEET and Miner1 are
considered to be the central regulators for energy metabolism,
iron homeostasis, and production of reactive oxygen species in
mitochondria (13), the specific function of the [2Fe-2S] clusters
in mitoNEET andMiner1 remains largely elusive. Recent stud-
ies have suggested that mitoNEET may transfer its [2Fe-2S]
clusters to target proteins in the cytoplasm to promote iron-
sulfur cluster biogenesis in the cytoplasm (14, 15). Alterna-
tively, mitoNEET may directly regulate mitochondrial func-
tions via redox transition of its [2Fe-2S] clusters (16–18). In
either case, binding of nitric oxide in the [2Fe-2S] cluster in
mitoNEET orMiner1 could potentially modulate the functions
of these mitochondrial proteins. There are at least 60 more
proteins that may host one or more [2Fe-2S] clusters via three
cysteine and one histidine residues in human cells (46).
Whether the [2Fe-2S] clusters in these newly identified pro-
teins can bind nitric oxide remains to be investigated.
To conclude, humanmitochondrial proteinMiner2 [2Fe-2S]
clusters can bind nitric oxidewithout disruption of the clusters.
Although the [2Fe-2S] cluster in purified mitoNEET and
Miner1 fails tobindnitric oxide, a subtle structural change in these
proteins can facilitate nitric oxide binding in the [2Fe-2S] cluster.
Binding of nitric oxide in the CDGSH-type [2Fe-2S] clusters of
mitochondrial proteinsmay represent a newnitric oxide signaling
mode tomodulate mitochondrial functions in human cells.
Experimental Procedures
Protein Preparation—The DNA fragments encoding human
mitochondrial CDGSH-type iron-sulfur proteins (mitoNEET,
containing residues 33–108 (4); Miner1, containing residues
57–135 (5); and Miner2 (containing residues 36–127)), were
synthesized (Genscript Co.) and cloned into the pET28b plas-
mid for expression in E. coli cells. The MitoNEET mutant
and Miner1 mutant were constructed using a site-directed
mutagenesis kit (Agilent Co.). The clonedDNA sequenceswere
confirmed by direct sequencing (Eurofins MWG Operon).
E. coli cells containing expression plasmids were diluted 1:100
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FIGURE 4. Mass spectra of human Miner2 before and after nitric oxide
treatment. Purified Miner2 (containing 20 M [2Fe-2S] cluster) was reduced
with dithiothreitol (4mM) under anaerobic conditions, followedby treatment
with 50M nitric oxide. Miner2 was then repurified from the incubation solu-
tion and subjected to mass spectrometry analyses. A, deconvoluted mass
spectra of theMiner2 [2Fe-2S] clusters before andafter nitric oxide treatment.
B, deconvoluted mass spectra of apo-Miner2 before and after nitric oxide
treatment. Red curve, Miner2 before nitric oxide treatment; blue curve, Miner2
after nitric oxide treatment.
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bated at 37 °C with aeration (250 rpm) for 3 h, followed by
protein induction using isopropyl 1-thio--D-galactopyrano-
side (100 M) overnight at 18 °C. Apo-Miner2 (Miner2 without
iron-sulfur clusters) was prepared following the same proce-
dures, except 0.5 mM dipyridyl was added to the Luria-Bertani
medium15min before isopropyl 1-thio--D-galactopyranoside
was added to induce the expression of Miner2 in E. coli cells.
Protein was purified as described previously (35). The purity of
purified proteins was greater than 95%, as judged by electro-
phoresis analysis on a 15% polyacrylamide gel containing SDS
followed by staining with Coomassie Blue. The UV-visible
absorption spectra were recorded in a Beckman DU640 UV-visi-
ble absorption spectrometer equipped with a temperature con-
troller. The full UV-visible absorption spectrum and SDS-PAGE
of purified humanMiner2 are shown in supplemental Fig. 1.
Nitric Oxide Solution Preparation—Nitric oxide gas (Air Co.)
was first passed through a soda-lima column to remove NO2
and higher nitrogen oxides before being used to bubble prede-
gassed water in a sealed 50-ml flask for 5 min. The concentra-
tion of nitric oxide in the nitric oxide-saturated solution was
measured using a nitric oxide electrode (World Precision
Instruments) (33). The nitric oxide-releasing reagent diethyl-
amine NONOate (Cayman Chemicals) was also used for pre-
paring nitric oxide solutions. Diethylamine NONOate was first
dissolved in buffer containing Tris (20 mM (pH 10.5)). The
NONOate concentration was determined from the absorption
peak at 250 nm using an extinction coefficient of 6.5
mM1cm1. Diethylamine NONOate releases 1.5 mol of nitric
oxide at a half-life time of 2min at 37 °C (pH7.4). Similar results
were obtainedwhen the nitric oxide gas solution or theNONO-
ate solution was used in the experiments.
Iron, Sulfide, and Nitrite Determinations—The total acid-la-
bile iron content in protein samples was determined using an
iron indicator, FerroZine, following the procedures described
in Ref. 47. The total acid-labile sulfide content in protein sam-
ples was determined following the procedures described by Sie-
gel (48). Nitric oxide bound inMiner2 was released by incubat-
ing the protein with 10mM L-cysteine at 37 °C for 30min under
aerobic conditions. The total nitrite content in samples was
measured usingGriess reagents according to the instructions of
the manufacturer (Cayman Chemicals) (26). The detection
limit of the Griess assay for nitrite was about 1.0 M. The ratios
of iron, sulfide, and nitrite tomonomericMiner2 are presented.
EPRMeasurements—TheX-bandEPR spectrawere recorded
using a Bruker model ESR-300 spectrometer equipped with an
Oxford Instruments 910 continuous flow cryostat. Routine EPR
conditions were as follows: microwave frequency, 9.47 GHz;
microwave power, 10.0 milliwatt; modulation frequency, 100
kHz; modulation amplitude, 1.2 millitesla; temperature, 20 K;
receiver gain, 2  105. The EPR spectrum simulation software
was kindly provided by Dr. Evert Duin (Auburn University).
Mass Spectrometry Measurements—All experiments were
performed with an AmaZon speed electron transfer dissocia-
tion (ETD) ion trap mass spectrometer (Bruker Daltonics, Bil-
lerica, MA). Sample solution was infused via an Apollo II elec-
trospray ionsourceusingasyringepumpata flowrateof5l/min.
MS detection was performed in a full-scan mode in positive ion-
ization-enhanced resolution mode with a scan speed of 8100
m/z/s. The parameter settings for electrospray ionization-mass
spectrometry (ESI-MS) were as follows: capillary voltage, 4500 V;
endplateoffset,500V;nebulizer, 8p.s.i.; drygas, 4 liters/min;dry
gas temperature, 180 °C.MS data were acquired from 300 to 3000
with a target mass of 1500 m/z and trap drive level of 100%. The
software used for data processing and deconvolution was Com-
pass DataAnalysis (Bruker Daltonics).
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FIGURE 5. Nitric oxide binding in the [2Fe-2S] cluster of the mitoNEET mutant D96V. Purified mitoNEET (containing 20 M [2Fe-2S] cluster) in buffer
containing NaCl (500mM) and Tris (20mM (pH 8.0)) was reducedwith dithiothreitol (4mM) under anaerobic conditions, followed by stepwise addition of nitric
oxide (fromanitric oxide-saturated solution). Spectrawere taken after each addition of nitric oxide. Final concentrations of nitric oxide are shown.O.D., optical

















FIGURE 6.Proposed model for nitric oxide binding in the reduced Miner2
[2Fe-2S] clusters. There are two [2Fe-2S] clusters in each Miner2. The first
[2Fe-2S] cluster hosted by three cysteine andonehistidine residues inMiner2
is shown. For the reduced Miner2 [2Fe-2S] cluster, the iron atom bound with
His/Cys residues is in a ferrous state, and nitric oxide binds the ferrous iron in
the [2Fe-2S] cluster.
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